Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Biden’s Cancer Initiative May Intensify Industry, Government Collaboration

Executive Summary

Drug companies and NIH embrace Vice President’s call for moonshot to cure cancer; Amgen and Celgene join separate coalition to test 60 molecules in combination Phase II studies.

Advertisement

Related Content

Clinical Trial Challenges: FDA Wants More Prospective Studies, Validated Biomarkers
Trump’s Election Could Bring ‘Best Of Times’ For Pharma
Cancer 'Moonshot' Recommendations On R&D Have Strong Patient Focus
Cancer Moonshot Initiative: FDA To Form Virtual Oncology Center of Excellence
Senate Medical Innovation Bill: Will Slow, Small And Steady Win The Race?
Where The Moonshot Meets The Road: Could Biden's Plan Boost Cures Bill?
Deal Watch: Amgen Takes Center Stage With Trio Of Transactions
In Buzz Of 2015 Pharma Dealmaking, Immuno-Oncology Is Queen Bee

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS057377

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel